IDH1/2 Mutations Are Maintained in a Subset of Patients with Acute Myeloid Leukemia in Complete Remission and Do Not Correlate with Residual Disease
Marconi, G., Bandini, L., Patuelli, A., Sartor, C., Parisi, S., Nanni, J., et al. (2021). IDH1/2 Mutations Are Maintained in a Subset of Patients with Acute Myeloid Leukemia in Complete Remission and Do Not Correlate with Residual Disease. BLOOD, 138, 4446-4448.
IDH1/2 Mutations Are Maintained in a Subset of Patients with Acute Myeloid Leukemia in Complete Remission and Do Not Correlate with Residual Disease
Giovanni Marconi;Bandini L;Patuelli A;Nanni J;Gianluca Cristiano;Giorgia Simonetti;Maria Teresa Bochicchio;Ottaviani E;
2021
Abstract
IDH1/2 Mutations Are Maintained in a Subset of Patients with Acute Myeloid Leukemia in Complete Remission and Do Not Correlate with Residual DiseaseFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


